| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | efmoroctocog alfa (Elocta®) |
| Formulation | powder and solvent for solution for injection |
| Reference number | 829 |
| Indication | Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency) |
| Company | Swedish Orphan Biovitrum Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 17/12/2015 |